DE69635114D1 - Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids - Google Patents

Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids

Info

Publication number
DE69635114D1
DE69635114D1 DE69635114T DE69635114T DE69635114D1 DE 69635114 D1 DE69635114 D1 DE 69635114D1 DE 69635114 T DE69635114 T DE 69635114T DE 69635114 T DE69635114 T DE 69635114T DE 69635114 D1 DE69635114 D1 DE 69635114D1
Authority
DE
Germany
Prior art keywords
inhibitors
aids
syn
treatment
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635114T
Other languages
English (en)
Other versions
DE69635114T2 (de
Inventor
Mari Yonemoto
Kenji Tanaka
Yoshikazu Iwasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of DE69635114D1 publication Critical patent/DE69635114D1/de
Application granted granted Critical
Publication of DE69635114T2 publication Critical patent/DE69635114T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69635114T 1995-08-09 1996-08-08 Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids Expired - Fee Related DE69635114T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22465995 1995-08-09
JP22465995 1995-08-09
PCT/JP1996/002241 WO1997005902A1 (fr) 1995-08-09 1996-08-08 Composition medicinale

Publications (2)

Publication Number Publication Date
DE69635114D1 true DE69635114D1 (de) 2005-09-29
DE69635114T2 DE69635114T2 (de) 2006-03-02

Family

ID=16817199

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635114T Expired - Fee Related DE69635114T2 (de) 1995-08-09 1996-08-08 Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids

Country Status (5)

Country Link
US (1) US6083985A (de)
EP (1) EP0856315B1 (de)
AT (1) ATE302613T1 (de)
DE (1) DE69635114T2 (de)
WO (1) WO1997005902A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
GB9801231D0 (en) 1997-06-05 1998-03-18 Merck & Co Inc A method of treating cancer
UA57081C2 (uk) * 1997-06-16 2003-06-16 Пфайзер Продактс Інк. Фармацевтична композиція для лікування раку або доброякісних проліферативних хвороб у ссавців, спосіб лікування, фармацевтична композиція для інгібування ненормального росту клітин у ссавців та спосіб інгібування
US20030114503A1 (en) * 1997-06-16 2003-06-19 Pfizer Inc. Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer
HUP0102473A3 (en) * 1997-12-22 2003-07-28 Schering Corp Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
CA2353867C (en) * 1998-12-09 2013-10-08 The Arizona Disease Control Research Commission Anticancer agents based on prevention of protein prenylation
US6191147B1 (en) * 1998-12-24 2001-02-20 Ppd Discovery, Inc. Pyrazole compounds and uses thereof
CA2363088A1 (en) * 1999-02-11 2000-08-17 Patrick T. Prendergast Methods for treating viral infections
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
AU2002218436A1 (en) 2000-12-19 2002-07-01 Pfizer Products Inc. Crystal forms of 6-((4-chloro-phenyl) -hydroxy-(-3-methyl- 3h-imidaol-4-yl) -methyl) -4-(3-ethynyl-phenyl) -1-methyl-1h- quinolin-2-one, 2,3- dihydroxybutanedioate salts and method of production
US20020151563A1 (en) * 2001-03-29 2002-10-17 Pfizer Inc. Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
US6602907B1 (en) * 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
US6740757B2 (en) 2001-08-29 2004-05-25 Pfizer Inc Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
WO2010075887A1 (en) * 2008-12-30 2010-07-08 Oxyrane (Uk) Limited Methods and intermediates useful in the synthesis of hexahydrofuro[2,3-b]furan-3-ol
US10369220B2 (en) * 2016-10-04 2019-08-06 Cellprint Ip Holding, Llc Methods and compositions for affecting immunological responsiveness

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044333A1 (en) * 1990-06-12 1991-12-13 Jackson B. Gibbs Chemotherapeutic agents
CA2080158A1 (en) * 1991-10-11 1993-04-12 Scott A. Biller Method for blocking neoplastic transformation of cells induced by ras oncogenes employing bisphosphonates or analogs thereof
US5286895A (en) * 1992-02-19 1994-02-15 Merck & Co., Inc. Cholesterol lowering compounds
JPH07316076A (ja) * 1994-05-24 1995-12-05 Sankyo Co Ltd 制癌剤
AU3192395A (en) * 1994-08-11 1996-03-07 Banyu Pharmaceutical Co., Ltd. Substituted amide derivative
JP2000501063A (ja) * 1995-06-29 2000-02-02 メルク エンド カンパニー インコーポレーテッド ファルネシル−タンパク質トランスフェラーゼ阻害剤の組み合わせ

Also Published As

Publication number Publication date
EP0856315A4 (de) 2003-04-23
US6083985A (en) 2000-07-04
EP0856315B1 (de) 2005-08-24
ATE302613T1 (de) 2005-09-15
WO1997005902A1 (fr) 1997-02-20
EP0856315A1 (de) 1998-08-05
DE69635114T2 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
DE69635114D1 (de) Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
HUP9900962A2 (hu) Fertőtlenítőkészítmények és eljárások felületek fertőtlenítésére
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
DE69910368D1 (de) Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69434459D1 (de) Zusammensetzung, welche apoptosis verhindert, methode zur reinigung dieser zusammensetzung und verwendungen davon
DE69825048D1 (de) Analoga von duocarmycin and cc-1065
DE60041394D1 (de) N-Acetylhydroxyprolin zur Verbesserung der Feuchtigkeitsspeicherungsfunktion der Epidermis
DE69831566T2 (de) Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
DE50010115D1 (de) Zusammensetzung und verfahren zur entkeimung von luft
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
ATE282317T1 (de) Antimikrobielle zusammensetzung zur behandlung von rindermastitis
ES2082012T3 (es) Inhibidores de la enzima beta-liasa de aminoacido como desodorantes.
ATE283044T1 (de) Compactin zur behandlung von entzündungen
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
TR199801335T2 (xx) Dezenfekte edici bile�imler ve y�zeylerin dezenfekte edilmesi i�in i�lemler.
DE60032002D1 (de) Verfahren zur herstellung von antimikrobiellen parfümierenden zusammensetzungen
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
PT972521E (pt) Composicao farmaceutica contendo estimuladores de interferao gama
ATE208202T1 (de) Verwendung von dimeticon zur behandlung der konstipation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee